[This corrects the article DOI: 10.3389/fmed.2022.850858.]
Favalli, E., Gobbini, A., Bombaci, M., Maioli, G., Biggioggero, M., Pesce, E., et al. (2022). Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) [Altro] [10.3389/fmed.2022.923790].
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858)
Gobbini A.;Favalli A.;Bandera A.;Gori A.;
2022
Abstract
[This corrects the article DOI: 10.3389/fmed.2022.850858.]
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
attachment; filename*=UTF-8''fmed-09-923790.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
84.69 kB
Formato
Adobe PDF
|
84.69 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
